国产亚洲欧美日韩俺去了,人妻无码久久精品,亚洲人成影院在线观看,亚洲AV永久无码精品表情包

Chiesi  凱西  
凱西集團1935年成立于意大利帕爾馬市，2012年集團銷(xiāo)售額為11.07億歐元，比上一年增長(cháng)了4.7%。集團主要致力于呼吸系統疾病和特殊治療領(lǐng)域，在全球擁有25家分公司，藥品銷(xiāo)往60多個(gè)國家。藥品生產(chǎn)地在帕爾馬市、法國的Blois和巴西的Santana de Parnaiba。2012年研發(fā)投入為1.98億歐元，為銷(xiāo)售額的17.8%，同時(shí)公司計劃未來(lái)的研發(fā)投入將保持在該水平。帕爾馬市的研究中心與位于巴黎、美國Rockville和英國Chippenham的實(shí)驗室緊密合作，共同推進(jìn)集團的臨床前、臨床階段和注冊階段的研發(fā)項目。截至2012年底凱西集團擁有3800多名員工，其中440多名員工專(zhuān)業(yè)從事研發(fā)工作。

Founded in 1935 in Parma, Italy, Chiesi Farmaceutici currently has 25 affiliates worldwide and markets its therapeutics in over 60 countries. Chiesi's manufacturing plants in Parma, Blois (France) and Santana de Parnaiba (Brazil), and R&D centers in Parma, Paris, Rockville (USA) and Chippenham (UK) integrate their efforts to advance the Group's pre-clinical, clinical and registration programs. At the end of 2012, the Chiesi Group's total staff stood at over 3,800 people, more than 350 of whom are dedicated to R&D. The main areas of activity are in respiratory therapeutics and specialist medicine areas.